ZA913920B - Therapeutic compound - Google Patents

Therapeutic compound

Info

Publication number
ZA913920B
ZA913920B ZA913920A ZA913920A ZA913920B ZA 913920 B ZA913920 B ZA 913920B ZA 913920 A ZA913920 A ZA 913920A ZA 913920 A ZA913920 A ZA 913920A ZA 913920 B ZA913920 B ZA 913920B
Authority
ZA
South Africa
Prior art keywords
therapeutic compound
treatment
bronchitis
ofbronchitis
medicament
Prior art date
Application number
ZA913920A
Other languages
English (en)
Inventor
Mitchell Glass
Glass Mitchell
Joseph Campbell Williams
Campbell Williams Joseph
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZA913920B publication Critical patent/ZA913920B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA913920A 1990-05-24 1991-05-23 Therapeutic compound ZA913920B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52865790A 1990-05-24 1990-05-24

Publications (1)

Publication Number Publication Date
ZA913920B true ZA913920B (en) 1992-02-26

Family

ID=24106599

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA913920A ZA913920B (en) 1990-05-24 1991-05-23 Therapeutic compound

Country Status (12)

Country Link
EP (1) EP0458537B1 (ja)
JP (1) JPH04235133A (ja)
AT (1) ATE178336T1 (ja)
AU (1) AU648078B2 (ja)
CA (1) CA2043107A1 (ja)
DE (1) DE69131058T2 (ja)
DK (1) DK0458537T3 (ja)
ES (1) ES2129401T3 (ja)
GR (1) GR3029726T3 (ja)
IE (1) IE911698A1 (ja)
IL (1) IL98200A0 (ja)
ZA (1) ZA913920B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
DK0458536T3 (da) * 1990-05-24 1998-10-19 Zeneca Ltd Terapeutisk middel til behandling og forebyggelse af åndedrætsbesværsyndrom hos voksne
GB9113164D0 (en) * 1991-06-18 1991-08-07 Ici Plc Pharmaceutical agent
DE10138294C5 (de) * 2001-08-10 2006-09-28 Db Netz Ag Verfahren und Vorrichtung zum Auswechseln eines Fahrdrahtes an einer Oberleitung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000077A1 (en) * 1984-06-14 1986-01-03 Cortech, Inc. Human leukocyte elastase inhibitors prepared from pyogenic bacteria and methods for their purification
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
EP0345906B1 (en) * 1988-06-10 1996-03-13 Merck & Co. Inc. Unique elastase induced fibrinogen cleavage site antigens
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
NO177716C (no) * 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis

Also Published As

Publication number Publication date
DE69131058D1 (de) 1999-05-06
CA2043107A1 (en) 1991-11-25
GR3029726T3 (en) 1999-06-30
JPH04235133A (ja) 1992-08-24
IE911698A1 (en) 1991-12-04
DE69131058T2 (de) 1999-09-09
DK0458537T3 (da) 1999-10-18
IL98200A0 (en) 1992-06-21
ATE178336T1 (de) 1999-04-15
EP0458537A3 (en) 1992-07-08
AU648078B2 (en) 1994-04-14
AU7719491A (en) 1991-11-28
ES2129401T3 (es) 1999-06-16
EP0458537A2 (en) 1991-11-27
EP0458537B1 (en) 1999-03-31

Similar Documents

Publication Publication Date Title
TW249226B (ja)
GR3019179T3 (en) Flupirtine in combination with antiparkinsonica against muscle bracing
GB8806737D0 (en) Therapeutic composition & method
AU6857887A (en) Therapeutic agent
HK196596A (en) Use of ofloxacin or a salt thereof for preparing a topical preparation for treating otopathy
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
GR3019058T3 (en) 3-Arylcarbonyl-1-aminoalkyl-1H-indole containing antiglaucoma compositions
GR3019760T3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
EP0430551A3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
GR3018651T3 (en) Treatment of ocular hypertention with a synergistic combination
ZA913920B (en) Therapeutic compound
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
GR3022217T3 (en) Treatment of cataract with prostacyclin compounds
AU7719591A (en) Therapeutic agent
UA16000A1 (uk) Спосіб лікуваhhя гіпотрофії поросят